I'm LongbridgeAI, I can summarize articles.Corbus Pharmaceuticals CFO Sean F. Moran sold 12,000 common shares on August 7, 2026, at a weighted average price of $10.08 per share, totaling approximately $120,971. Following this transaction, his directly held stake in the company decreased to 84,694 shares. The information was published via EDGAR on August 10, 2026.
- Corbus Pharmaceuticals CFO Sean F. Moran sold 12,000 common shares on Aug. 7, 2026 at a weighted average price of USD 10.08. * Directly held stake fell to 84,694 shares following the sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-342479), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here